Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

127879 Press Releases
DateTitleCompany
29 Jun 16 Dimension Therapeutics to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference Published by
GlobeNewswire
29 Jun 16 Myriad’s myChoice® HRD Test Successfully Identifies Patients that Meet Primary Endpoint in TESARO’s Pivotal Phase 3 Ovarian Cancer Study with Niraparib Published by
GlobeNewswire
29 Jun 16 Galena Biopharma Discontinues NeuVax™ (nelipepimut-S) Phase 3, PRESENT Interim Analysis based on Independent Data Monitoring Committee Recommendation Published by
GlobeNewswire
29 Jun 16 Cara Therapeutics Initiates Adaptive Phase 2/3 Trial of I.V. CR845 for Treatment of Chronic Kidney Disease-Associated Pruritus Published by
GlobeNewswire
29 Jun 16 TESARO’s Niraparib Significantly Improved Progression-Free Survival for Patients With Ovarian Cancer in Both Cohorts of the Phase 3 NOVA Trial Published by
GlobeNewswire
29 Jun 16 Lipocine Receives Complete Response Letter (CRL) for LPCN 1021 From U.S. Food and Drug Administration Published by
GlobeNewswire
29 Jun 16 Atlas Genomics Enters into National Agreement with Henry Schein Medical to Offer Atlas Genomics’ Noninvasive Prenatal and Carrier Screen Tests Published by
GlobeNewswire
29 Jun 16 Cascadian Therapeutics Receives ONT-380 Fast Track Designation from FDA for the Treatment of Advanced HER2+ Metastatic Breast Cancer Published by
GlobeNewswire
29 Jun 16 Dextera Surgical Appoints Mark Soberman M.D., Leader in Thoracic Surgery, as Medical Director Published by
GlobeNewswire
29 Jun 16 Alder BioPharmaceuticals Appoints Timothy M. Whitaker, M.D., Chief Medical Officer Published by
GlobeNewswire
29 Jun 16 Argos Therapeutics Announces Closing of $29.8 Million Second Tranche of March 2016 Financing Published by
GlobeNewswire
29 Jun 16 Cancer Genetics, Inc. Expands Its Immuno-Oncology Franchise With The Addition of The FDA-Approved VENTANA PD-L1 (SP142) Assay As A Complementary Diagnostic Test For TECENTRIQ™ Published by
GlobeNewswire
29 Jun 16 Entellus Medical Acquires XeroGel™ from CogENT Therapeutics®, Strengthens Product Portfolio Published by
GlobeNewswire
29 Jun 16 Echo Therapeutics Begins Testing of NextGen CGM System Components Echo Therapeutics, Inc.,
Published by
PR Newswire
29 Jun 16 Aflac Study: Millennials Often Underestimate Health Care Costs Aflac,
Published by
PR Newswire
29 Jun 16 Now There's an App That Reminds Us to Put Down Our Phones and Enhance Human Connections Mode,
Published by
PR Newswire
29 Jun 16 Dr. Pankaj Naram and Air Pollution Study Dr. Pankaj Naram,
Published by
PR Newswire
29 Jun 16 California Cryobank Offers Free Sperm Storage to Olympic Athletes California Cryobank,
Published by
PR Newswire
29 Jun 16 Acceleron Announces Presentation of ACE-083 Phase 1 Healthy Volunteer Data at the 14th International Congress on Neuromuscular Disease Acceleron Pharma,
Published by
Business Wire
29 Jun 16 Mary's Medicinals Announces Sale of Millionth Transdermal Cannabis Patch Mary’s Medicinals,
Published by
PR Newswire
29 Jun 16 Natera and Illumina Extend Supply Agreement, Broaden Existing Partnership to Include Oncology Field Natera, Inc.,
Published by
PR Newswire
29 Jun 16 Iroko Pharmaceuticals Secures Debt Financing From CRG Iroko Pharmaceuticals, LLC,
Published by
PR Newswire
29 Jun 16 CareDx Responds to CMS Proposal to Cut AlloMap Pricing by 74% CareDx,
Published by
PR Newswire
29 Jun 16 Braeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Albany on July 8 and 9 for Qualified Healthcare Providers Braeburn Pharmaceuticals,
Published by
PR Newswire
29 Jun 16 Braeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Atlanta on July 8, 9 and 10 for Qualified Healthcare Providers Braeburn Pharmaceuticals,
Published by
PR Newswire
29 Jun 16 Braeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Charleston on July 8, 9 and 10 for Qualified Healthcare Providers Braeburn Pharmaceuticals,
Published by
PR Newswire
29 Jun 16 Braeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Grand Rapids on July 8 and 9 for Qualified Healthcare Providers Braeburn Pharmaceuticals,
Published by
PR Newswire
29 Jun 16 Braeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Orlando on July 8, 9 and 10 for Qualified Healthcare Providers Braeburn Pharmaceuticals,
Published by
PR Newswire
29 Jun 16 BioPharmX Announces Positive Topline Phase 2a Clinical Trial Results for BPX-01 in Patients with Acne-Causing Bacteria BioPharmX Corporation,
Published by
PR Newswire
29 Jun 16 Juniper Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference Juniper Pharmaceuticals, Inc.,
Published by
PR Newswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.